{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:56:34Z","timestamp":1787316994602,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-01527"],"award-info":[{"award-number":["2016-01527"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008546","name":"Diabetesf\u00f6rbundet","doi-asserted-by":"publisher","award":["DIA 2017-205"],"award-info":[{"award-number":["DIA 2017-205"]}],"id":[{"id":"10.13039\/501100008546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["9321-430"],"award-info":[{"award-number":["9321-430"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["10033852"],"award-info":[{"award-number":["10033852"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["KAW 2017.0203"],"award-info":[{"award-number":["KAW 2017.0203"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20120533"],"award-info":[{"award-number":["20120533"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.atherosclerosis.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T09:04:23Z","timestamp":1547975063000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Deciphering the role of V200A and N291S mutations leading to LPL deficiency"],"prefix":"10.1016","volume":"282","author":[{"given":"Margherita","family":"Botta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-7061","authenticated-orcid":false,"given":"Massimiliano","family":"Ruscica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Stulnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-225X","authenticated-orcid":false,"given":"Piero","family":"Pingitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacl.2015.12.015","article-title":"Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency","volume":"10","author":"Rodrigues","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00041433-200004000-00006","article-title":"Endothelial lipase: a new member of the triglyceride lipase gene family","volume":"11","author":"Rader","year":"2000","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib3","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1194\/jlr.R200015-JLR200","article-title":"Lipoprotein lipase: genetics, lipid uptake, and regulation","volume":"43","author":"Merkel","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.atherosclerosis.2014.10.016","article-title":"Lipoprotein lipase: from gene to atherosclerosis","volume":"237","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib5","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1172\/JCI35206","article-title":"Molecular processes that handle \u2013 and mishandle \u2013 dietary lipids","volume":"118","author":"Williams","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/01.ATV.15.8.1086","article-title":"Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins","volume":"15","author":"Tornvall","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0003-3995(01)01037-1","article-title":"Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6","volume":"44","author":"Gilbert","year":"2001","journal-title":"Ann. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cccn.2004.01.029","article-title":"Missense mutation W86R in exon 3 of the lipoprotein lipase gene in a boy with chylomicronemia","volume":"343","author":"Pasali\u0107","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/humu.10212","article-title":"Human gene mutation database (HGMD): 2003 update","volume":"21","author":"Stenson","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(96)00005-8","article-title":"Molecular pathobiology of the human lipoprotein lipase gene","volume":"70","author":"Murthy","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0889-8529(05)70025-6","article-title":"The familial chylomicronemia syndrome","volume":"27","author":"Santamarina-Fojo","year":"1998","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib12","series-title":"GeneReviews\u00ae [Internet]. Seattle (WA)","article-title":"Familial lipoprotein lipase deficiency","author":"Brunzell","year":"2014"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.numecd.2017.11.003","article-title":"Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia","volume":"28","author":"Caddeo","year":"2018","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jacl.2016.02.015","article-title":"Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia","volume":"10","author":"Pingitore","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib15","first-page":"19","article-title":"Is plasmapheresis the optimal treatment option for acute pancreatitis secondary to hypertriglyceridemia? A systematic review","volume":"4","author":"Rehmanjan","year":"2013","journal-title":"Acad. Market. Stud. J."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4103\/0972-5229.162472","article-title":"Early plasmapheresis in patients with severe hypertriglyceridemia induced acute pancreatitis","volume":"19","author":"Nasa","year":"2015","journal-title":"Indian J. Crit. Care Med."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1089\/hum.2018.007","article-title":"Gene therapy in lipoprotein lipase deficiency: case report on the first patient treated with alipogene tiparvovec under daily practice conditions","volume":"29","author":"Kassner","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3835-c1","article-title":"Regulatory evaluation of Glybera in Europe - two committees, one mission","volume":"12","author":"Melchiorri","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14712598.2013.738663","article-title":"Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency","volume":"13","author":"Wierzbicki","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nbt0617-491","article-title":"After Glybera's withdrawal, what's next for gene therapy?","volume":"35","author":"Senior","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib21","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0022-2275(20)39922-3","article-title":"Lipoprotein lipase deficiency due to a 3' splice site mutation in intron 6 of the lipoprotein lipase gene","volume":"35","author":"H\u00f6lzl","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0021-9150(99)00398-6","article-title":"Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia","volume":"151","author":"Schmaldienst","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.atherosclerosis.2016.08.023","article-title":"The role of registries in rare genetic lipid disorders: review and introduction of the first global registry in lipoprotein lipase deficiency","volume":"262","author":"Steinhagen-Thiessen","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5551\/jat.11.131","article-title":"Mutations in Japanese subjects with primary hyperlipidemia\u2013results from the research committee of the ministry of health and welfare of Japan since 1996\u2013","volume":"11","author":"Maruyama","year":"2004","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-9150(97)88233-0","article-title":"Molecular and environmental bases of primary type IV hyperlipoproteinemia: heterozygous lipoprotein lipase deficiency as a causal genetic disorder","volume":"134","author":"Takagi","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng0595-28","article-title":"A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis","volume":"10","author":"Reymer","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.CIR.97.8.729","article-title":"A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia","volume":"97","author":"Wittekoek","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-5793(95)00582-T","article-title":"The mutant Asn291-->Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin","volume":"367","author":"Busc\u00e0","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/(SICI)1098-1004(1997)10:6<465::AID-HUMU8>3.0.CO;2-C","article-title":"Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy","volume":"10","author":"Mailly","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0004563213477393","article-title":"Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene","volume":"50","author":"Overgaard","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0022-2275(20)30146-2","article-title":"Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene","volume":"43","author":"Peterson","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1093-3263(00)00096-6","article-title":"Structure-function analysis of D9N and N291S mutations in human lipoprotein lipase using molecular modelling","volume":"19","author":"Razzaghi","year":"2001","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacl.2012.11.006","article-title":"Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat","volume":"7","author":"Blackett","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib37","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1016\/S0021-9258(19)81302-9","article-title":"A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II","volume":"263","author":"Fojo","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.mol.0000217892.00618.54","article-title":"APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency","volume":"17","author":"Calandra","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.01.004_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"P\u00e9terfy","year":"2007","journal-title":"Nat. Genet."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019300103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019300103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:23:39Z","timestamp":1762187019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019300103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":39,"alternative-id":["S0021915019300103"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.004","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the role of V200A and N291S mutations leading to LPL deficiency","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}